Wedbush Securities’s Viking Therapeutics VKTX Stock Holding History

Wedbush Securities’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,400	Closed	-$268K	–	1281
2023 Q4	$268K	Hold	14,400	–	–	0.01%	822
2023 Q3	$159K	Hold	14,400	–	–	0.01%	953
2023 Q2	$233K	Hold	14,400	–	–	0.01%	867
2023 Q1	$240K	Sell	14,400 -400	-3%	-$4.13K	0.01%	847
2022 Q4	$139K	Hold	14,800	–	–	0.01%	959
2022 Q3	$40K	Hold	14,800	–	–	﹤0.01%	1015
2022 Q2	$43K	Hold	14,800	–	–	﹤0.01%	1038
2022 Q1	$44K	Hold	14,800	–	–	﹤0.01%	1080
2021 Q4	$68K	Sell	14,800 -1,700	-10%	-$9.53K	﹤0.01%	1147
2021 Q3	$104K	Buy	+16,500	New	+$102K	﹤0.01%	1130
2021 Q2	–	Sell	-16,500	Closed	-$104K	–	1195
2021 Q1	$104K	Sell	16,500 -2,500	-13%	-$17.6K	0.01%	1043
2020 Q4	$107K	Sell	19,000 -2,500	-12%	-$15.1K	0.01%	828
2020 Q3	$125K	Buy	21,500 +2,500	+13%	+$17.2K	0.01%	806
2020 Q2	$137K	Hold	19,000	–	–	0.01%	832
2020 Q1	$89K	Sell	19,000 -207	-1%	-$1.27K	0.01%	782
2019 Q4	$154K	Hold	19,207	–	–	0.01%	897
2019 Q3	$132K	Buy	19,207 +7,500	+64%	+$55.7K	0.01%	874
2019 Q2	$97K	Buy	+11,707	New	+$100K	0.01%	906

Other funds holding VKTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Wedbush Securities's VKTX Position: Q1 2024 in Review

Wedbush Securities sold out of Viking Therapeutics (VKTX) in Q1 2024, closing a stake of 14,400 shares — an estimated $268K sold.

Wedbush Securities first reported a position in VKTX in Q2 2019 and held it in 18 quarters. The position peaked at $268K in Q4 2023. 375 funds tracked by Wall St. Rank hold VKTX as of Q1 2024.

Wedbush Securities reported no remaining Viking Therapeutics position as of Q1 2024 after selling out during the quarter.
Wedbush Securities sold 14,400 Viking Therapeutics shares in Q1 2024, an estimated $268K.
Wedbush Securities first reported a position in Viking Therapeutics in Q2 2019 and held it in 18 quarters.
Wedbush Securities's Viking Therapeutics position peaked at $268K in Q4 2023.
375 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2024.

Based on Wedbush Securities's 13F filing for Q1 2024, filed 15 May 2024.